person · Reporting owner

Cleaver Heath

Disclosed activity across 1 company

Tapewire entity: 88599
SEC CIK: 0001599765

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
BIO-PATH HOLDINGS, INC.BPTH · Entity 9692	Director	July 30, 2024	August 01, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

BIO-PATH HOLDINGS, INC.

Report date July 30, 2024 · Filed August 01, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.55 · Expires 2024-07-30	Direct	2,000	Reported balance After 2024-07-30 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2024-07-30 · Grant · Acquired 2,000 · Balance 2,000 F1: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 2,000 shares, based on continuing service to Bio-PathHoldings, Inc.

Filing footnotes · ownership attribution and instrument terms

F1: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 2,000 shares, based on continuing service to Bio-PathHoldings, Inc.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
July 30, 2024 Filed Aug 1, 2024 22:07 UTC	BIO-PATH HOLDINGS, INC. BPTH · Entity 9692	GrantCommon Stock Option (right to buy) · Derivative	2,000	$0.00 Strike: $1.55	$0.00	Disclosure SEC source: 0001446472-24-000006 · primary_doc.xml · derivative · entry 1 Cleaver Heath · CIK 0001599765 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2024-07-30 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 2,000 shares, based on continuing service to Bio-PathHoldings, Inc. Read SEC document
May 02, 2023 Filed May 4, 2023 22:24 UTC	BIO-PATH HOLDINGS, INC. BPTH · Entity 9692	GrantCommon Stock Option (right to buy) · Derivative	10,000	$0.00 Strike: $1.39	$0.00	Disclosure SEC source: 0001446472-23-000014 · primary_doc.xml · derivative · entry 1 Cleaver Heath · CIK 0001599765 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2033-05-02 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 10,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document
March 28, 2022 Filed Mar 30, 2022 21:42 UTC	BIO-PATH HOLDINGS, INC. BPTH · Entity 9692	GrantCommon Stock Option (right to buy) · Derivative	10,000	$0.00 Strike: $3.79	$0.00	Disclosure SEC source: 0001599765-22-000001 · primary_doc.xml · derivative · entry 1 Cleaver Heath · CIK 0001599765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-03-28 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 10,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document
March 31, 2021 Filed Mar 31, 2021 23:59 UTC	BIO-PATH HOLDINGS, INC. BPTH · Entity 9692	GrantCommon Stock Option (right to buy) · Derivative	10,000	$0.00 Strike: $7.02	$0.00	Disclosure SEC source: 0001599765-21-000001 · primary_doc.xml · derivative · entry 1 Cleaver Heath · CIK 0001599765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-03-31 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 10,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document
March 27, 2020 Filed Mar 31, 2020 20:57 UTC	BIO-PATH HOLDINGS, INC. BPTH · Entity 9692	GrantCommon Stock Option (right to buy) · Derivative	10,000	$0.00 Strike: $5.07	$0.00	Disclosure SEC source: 0001444954-20-000003 · primary_doc.xml · derivative · entry 1 Cleaver Heath · CIK 0001599765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-03-27 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 10,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document
March 28, 2019 Filed Apr 1, 2019 23:26 UTC	BIO-PATH HOLDINGS, INC. BPTH · Entity 9692	GrantCommon Stock Option (right to buy) · Derivative	1,000	$0.00 Strike: $18.40	$0.00	Disclosure SEC source: 0001599765-19-000003 · primary_doc.xml · derivative · entry 1 Cleaver Heath · CIK 0001599765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2029-03-28 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 1,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document
April 17, 2018 Filed Apr 19, 2018 20:53 UTC	BIO-PATH HOLDINGS, INC. BPTH · Entity 9692	GrantCommon Stock Option (right to buy) · Derivative	20,000	$0.00 Strike: $1.68	$0.00	Disclosure SEC source: 0001599765-18-000001 · primary_doc.xml · derivative · entry 1 Cleaver Heath · CIK 0001599765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-04-17 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 20,000 shares vesting on the first anniversary of April 17, 2018 and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 20,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document
March 23, 2017 Filed Mar 27, 2017 20:51 UTC	BIO-PATH HOLDINGS, INC. BPTH · Entity 9692	GrantCommon Stock Option (right to buy) · Derivative	25,000	$0.00 Strike: $0.80	$0.00	Disclosure SEC source: 0001007382-17-000004 · primary_doc.xml · derivative · entry 1 Cleaver Heath · CIK 0001599765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-03-23 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 25,000 shares vesting on the first anniversary of March 23, 2017 and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 25,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.